Skip to main content
Clinical Trials/NCT03742856
NCT03742856UnknownNot Applicable

A Multi-omics Study on the Invasiveness of Epithelial Ovarian Cancer

Lei Li1 site in 1 country80 target enrollmentStarted: November 10, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Frequencies of somatic driving mutations

Study Overview

Brief Summary

This study aims to analyze the multi-omics results between epithelial ovarian cancer (EOC) patient with different FIGO stages and pathological subtypes. The multi-omics profiles include whole exome sequencing, analysis of transcriptomics and metabolomics. A comprehensive multi-omics will reveal the invasiveness and tumorigenesis of EOC.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed primary epithelial ovarian cancer
  • Signed an approved informed consents
  • Feasible for biopsy

Exclusion Criteria

  • Not meeting all of the inclusion criteria

Outcomes

Primary Outcomes

Frequencies of somatic driving mutations

Time Frame: Two years

The differences of frequencies of somatic driving mutations will be compared between patients of different FIGO stages and different pathological subtypes.

Secondary Outcomes

  • Progression-free survival(Five years)
  • Frequencies of alteration of RNA expression(Two years)
  • Frequencies of alteration of protein expression and signal pathway(Two years)

Investigators

Sponsor
Lei Li
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Lei Li

Professor

Peking Union Medical College Hospital

Study Sites (1)

Loading locations...

Similar Trials

A Multi-omics Study of Epithelial Ovarian... | Clinical Trial